Menu ×

HEALTHCARE & PHARMACEUTICAL

Typhoid Antibody Testing Market Analysis by Product Type {WIDAL Test, Typhidot Test, and Rapid Serological Tests (Counter Immunoelectrophoresis, Hem-agglutination & Co-agglutination, and Others)}; and by End-User (Serological Testing Centers, Hospitals, Diagnostic Centers, Clinics, and Other Healthcare Facilities) – Global Supply & Demand Analysis & Opportunity Outlook 2022-2031

  • Text Size:

Extensive insights into the Growth of Typhoid Antibody Testing Market amidst COVID-19

Get the detailed impact analysis of COVID-19 that has disrupted the entire world and affected many industries.

Request Insights


IN THE NEWS

  • September, 2019: IDL Biotech AB launched TUBEX TF, rapid test for typhoid fever in Kenya. Launch took place at Kenya Medical Research Institute in presence of doctors, pathologists, and representatives from Ministry of Health.
  • March, 2018: Thermo Fisher Scientific, a market leader in microbiology, mass spectrometry systems was entitled with AFNOR certification for  Thermo Scientific RapidFinder Salmonella Multiplex   PCR Solution which aims at sample preparation and producing results in approximately 16 hours. This test is performed in laboratories for poultry produced to reduce the risk associated with Salmonella and other diseases.

Global Typhoid Antibody Testing Market Size, Forecast, and Trend Highlights Over 2022 - 2031

Typhoid-Antibody-Testing-Market-Scope

The global typhoid antibody testing market is estimated to garner a moderate revenue by the end of 2031 by growing at a CAGR of ~7% over the forecast period, i.e., 2022 – 2031. Further, the market generated a modest revenue in the year 2021. The market is estimated to grow on the back of rapid increase in typhoid cases globally as an instance of poor sanitation practices. According to the report by the World Health Organization (WHO), till 2030, 1.6 billion people around the world are estimated to lack proper safe drinking water and 2.8 billion people are expected to be not able to attain safe sanitation services. For instance, in India, more than 4 million cases are diagnosed with typhoid every year due to improper sanitation practices.  

Typhoid-Antibody-Testing-Market

Get more information on this report: Request Sample PDF

The global typhoid antibody testing market is also estimated to witness growth on account of rising government efforts to make people aware of typhoid, developing nursing facilities and managing the number of cases in their respective regions. Moreover, the increasing ratio of typhoid cases in developing nations where sanitary conditions are poor are anticipated to raise the market growth. On October 2017, the Strategic Advisory Group of Experts (SAGE) on immunization, recommended a typhoid conjugate vaccine for children above 6 months in countries with high cases of typhoid. SAGE is the same body that advises World Health Organization in regards to immunization and vaccines.

Global Typhoid Antibody Testing Market: Growth Drivers and Challenges

Growth Drivers

  • Increased Rate of Morbidity and Mortality in Typhoid CasesAccording to the data by the World Health Organization (WHO), around 11 – 20 million people are known to have typhoid disease and between 128,000 and 161,000 people are known to die as a result of the disease every year.
  • Increased Competition Among Competitors – For instance, WIDAL antigen test is inexpensive and easily be done in few minutes but it takes long time of around 10 days to produce the result. This factor is estimated to bring more competition among top manufacturers to produce fast, accurate and cost effective ways to diagnose typhoid.
  • Government Support to Manage Typhoid CasesFor instance, “Swachh Bharat Mission” program was initiated by Indian government aims to improve the sanitation condition and waste management, as well as construction of community toilets throughout the country by 2019.
  • Lack of Safe Sanitation in Developing Countries – According to the United Nations Children’s Fund (UNICEF) and World Health Organization (WHO), 6 in 10 people globally i.e., around 4.5 billion people globally lacked proper sanitation condition at their homes.
  • Increased Health Expenditure – According to the data by World Bank, in 2019, the expenditure on health as a share of the GDP in Australia, India, and China touched 9.91%, 3.01%, and 5.35% respectively.

Typhoid-Antibody-Testing-Market

Challenges

  • Lacking Early Diagnosis of Enteric Symptoms
  • Lack of Awareness Related to Antibody Testing Kits
  • Patient’s Exposure to Other Antibiotics Prior Visiting to Healthcare Facility

The global typhoid antibody testing market is segmented and analyzed for demand and supply by end-user into hospitals, diagnostic centers, serological testing centers, clinics, and, other healthcare facilities. Out of these segments, the hospital segment is anticipated to garner the largest market share over the forecast period, owing to the availability of proper medical facilities in hospital premises in addition to the availability of advance technologies and treatment. Besides this, the surge in medical tourism industry is also projected to generate numerous growth opportunities for the segment in the coming years. According to the data by India Brand Equity Foundation (IBEF), in 2020, valuation of Indian medical tourism market was US$ 2.89 billion, which is further expected to touch US$ 13.42 billion by the end of 2026. Moreover, fast paced, advance technological equipment and people’s trust on highly qualified professional is estimated to fuel the growth of segment.

Typhoid-Antibody-Testing-Market-Demand

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Typhoid Antibody Testing Market Regional Synopsis

Regionally, the global typhoid antibody testing market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in Asia Pacific is projected to hold the largest market share by the end of 2031, backed by the increase in typhoid cases from developing countries such as India, China, Bangladesh, Nepal, Vietnam, and Laos. These countries report more than 75% of typhoid cases around the world. Moreover, various government led initiatives aiming at managing the number of cases and spreading awareness and preventive measures are some factors that are expected to enhance the market growth in this region. For instance, in 2019, more than 450,000 typhoid cases have been found in Bangladesh, of which about 7,400 cases result in death. In 2017, more than 104,000 cases of typhoid were estimated, of which about 56% were children under the age of 15.

Typhoid-Antibody-Testing-Market-Size

The global typhoid antibody testing market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global typhoid antibody testing market includes the following segments:

Typhoid-Antibody-Testing-Market-Analysis

Top Featured Companies Dominating the Global Typhoid Antibody Testing Market

  • IDL Biotech AB
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • LINEAR CHEMICALS, S.L.U
  • Medical Innovation Ventures Sdn Bhd
  • Thermo Fisher Scientific
  • Nectar Lifesciences Ltd.
  • DIALAB GmbH.
  • BIOSYSTEMS S.A.
  • Siemens Healthcare GmbH
  • NanoEnTek
  • CerTest Biotec S.L.

 

 

FREQUENTLY ASKED QUESTIONS


Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved